Insider Trade - Lo Andrew's Insider Stock Buys and Sells

Monthly Buy/Sell Ratio vs. Sector ETF Performance
Data has 3 months delay. Real time data for Premium Members only
Download Premium Members Only

Regions
Quick Select
Filters
Real time insider type: Display Stocks That are within: of
Display Those with At Least:
Default
Views
Default View
40/Page
Total 106
  • 1
  • 2
  • 3
Pages
More Views
Ticker Company Current Price Insider Name Insider Position Date Buy/Sell Insider Trading Shares Shares Change Price Cost Final Share Price Change Since Insider Trade (%) Dividend Yield % PE Ratio Market Cap ($M)
UROV Urovant Sciences Ltd$7.99 Lo Andrew 10% Owner 2019-06-19 Buy18,2040.08%$8.32151,45722,860,013-3.97%00242.34
UROV Urovant Sciences Ltd$7.99 Lo Andrew 10% Owner 2019-06-14 Buy22,0110.10%$8.06177,40922,841,809-0.87%00242.34
UROV Urovant Sciences Ltd$7.99 Lo Andrew 10% Owner 2019-06-11 Buy21,3380.09%$8.31177,31922,819,798-3.85%00242.34
UROV Urovant Sciences Ltd$7.99 Lo Andrew 10% Owner 2019-06-06 Buy21,1220.09%$7.86166,01922,798,4601.65%00242.34
DXCM DexCom Inc$147.66 Balo Andrew K * 2019-06-05 Sell7,82512.71%$125978,12569,39218.13%0013,444.50
MYOV Myovant Sciences Ltd$9.31 Lo Andrew 10% Owner 2019-06-04 Buy2,424,2426.32%$8.2520,000,00040,765,59912.85%00834.37
UROV Urovant Sciences Ltd$7.99 Lo Andrew 10% Owner 2019-06-03 Buy17,7460.08%$7.83138,95122,777,3382.04%00242.34
UROV Urovant Sciences Ltd$7.99 Lo Andrew 10% Owner 2019-05-29 Buy14,4850.06%$7.63110,52122,759,5924.72%00242.34
UROV Urovant Sciences Ltd$7.99 Lo Andrew 10% Owner 2019-05-23 Buy19,8300.09%$8.22163,00322,745,107-2.80%00242.34
UROV Urovant Sciences Ltd$7.99 Lo Andrew 10% Owner 2019-05-20 Buy21,6080.10%$7.54162,92422,725,2775.97%00242.34
AXGT Axovant Gene Therapies Ltd$6.41 Lo Andrew 10% Owner 2019-03-18 Buy6,666,6676.71%$1.5010,000,000105,952,381327.33%00146.01
DXCM DexCom Inc$147.66 Balo Andrew K * 2019-03-12 Sell10,91716.47%$142.791,558,84077,2173.41%0013,444.50
AXGT Axovant Gene Therapies Ltd$6.41 Lo Andrew 10% Owner 2018-12-18 Buy10,000,00011.20%$110,000,00099,285,714541%00146.01
DXCM DexCom Inc$147.66 Balo Andrew K EVP, Reg. Strategy, Clinical 2018-12-14 Sell5,0007.34%$121.23606,15073,10521.80%0013,444.50
DXCM DexCom Inc$147.66 Balo Andrew K EVP, Reg. Strategy, Clinical 2018-11-14 Sell5,0006.84%$143.13715,65078,1053.16%0013,444.50
DXCM DexCom Inc$147.66 Balo Andrew K EVP, Reg. Strategy, Clinical 2018-10-12 Sell5,0006.40%$124.79623,95083,10518.33%0013,444.50
UROV Urovant Sciences Ltd$7.99 Lo Andrew 10% Owner 2018-10-01 Buy2,678,57113.38%$1437,500,00022,703,669-42.93%00242.34
DXCM DexCom Inc$147.66 Balo Andrew K EVP, Reg. Strategy, Clinical 2018-09-14 Sell5,0006.02%$145.17725,85088,1051.72%0013,444.50
DXCM DexCom Inc$147.66 Balo Andrew K EVP, Reg. Strategy, Clinical 2018-09-10 Sell5,5876.38%$143.76803,18793,1052.71%0013,444.50
DXCM DexCom Inc$147.66 Balo Andrew K EVP, Reg. Strategy, Clinical 2018-08-14 Sell5,0005.34%$124.25621,25098,56718.84%0013,444.50
DXCM DexCom Inc$147.66 Balo Andrew K EVP, Reg. Strategy, Clinical 2018-07-16 Sell5,0005.07%$99.56497,800103,56748.31%0013,444.50
AXGT Axovant Gene Therapies Ltd$6.41 Lo Andrew 10% Owner 2018-06-05 Buy14,285,71419.05%$1.7525,000,00089,285,714266.29%00146.01
MYOV Myovant Sciences Ltd$9.31 Lo Andrew 10% Owner 2018-04-02 Buy1,110,0152.98%$20.2722,500,00038,341,357-54.07%00834.37
DXCM DexCom Inc$147.66 Balo Andrew K EVP, Reg. Strategy, Clinical 2017-12-11 Sell3,2454.25%$61.23198,69179,547141.16%0013,444.50
DXCM DexCom Inc$147.66 Balo Andrew K EVP, Reg. Strategy, Clinical 2017-11-29 Sell6,4908.51%$60389,40082,792146.10%0013,444.50
DXCM DexCom Inc$147.66 Balo Andrew K EVP, Reg. Strategy, Clinical 2017-09-11 Sell3,2443.77%$72.27234,44489,282104.32%0013,444.50
DXCM DexCom Inc$147.66 Balo Andrew K EVP, Reg. Strategy, Clinical 2017-08-10 Sell3,2443.35%$71.18230,90899,989107.45%0013,444.50
DXCM DexCom Inc$147.66 Balo Andrew K EVP, Reg. Strategy, Clinical 2017-07-10 Sell3,2003.20%$71.55228,960103,233106.37%0013,444.50
DXCM DexCom Inc$147.66 Balo Andrew K EVP, Clinical and Regulatory 2017-06-12 Sell3,2003.10%$69.06220,992106,433113.81%0013,444.50
DXCM DexCom Inc$147.66 Balo Andrew K EVP, Clinical and Regulatory 2017-05-10 Sell3,2003.01%$71.93230,176109,633105.28%0013,444.50
DXCM DexCom Inc$147.66 Balo Andrew K EVP, Clinical and Regulatory 2017-04-10 Sell3,2002.92%$78.19250,208112,83388.85%0013,444.50
DXCM DexCom Inc$147.66 Balo Andrew K EVP, Clinical and Regulatory 2017-03-10 Sell3,2002.84%$77.71248,672116,03390.01%0013,444.50
DXCM DexCom Inc$147.66 Balo Andrew K EVP, Clinical and Regulatory 2017-02-10 Sell3,2003.18%$79.30253,760103,87286.20%0013,444.50
DXCM DexCom Inc$147.66 Balo Andrew K EVP, Clinical and Regulatory 2017-01-10 Sell3,2003.10%$62.86201,152106,345134.90%0013,444.50
IVZ Invesco Ltd$20.46 Lo Andrew Tak Shing Senior Managing Director 2016-11-02 Sell150,000147.63%$27.714,156,500251,603-26.16%5.9110.439,750.70
DXCM DexCom Inc$147.66 Balo Andrew K EVP, Clinical and Regulatory 2016-10-19 Sell4,9974.93%$82.31411,303106,34579.39%0013,444.50
DXCM DexCom Inc$147.66 Balo Andrew K EVP, Clinical and Regulatory 2016-10-05 Sell5,0004.70%$82.55412,750111,34278.87%0013,444.50
DXCM DexCom Inc$147.66 Balo Andrew K EVP, Clinical and Regulatory 2016-09-21 Sell5,0004.49%$92.87464,350116,34259%0013,444.50
DXCM DexCom Inc$147.66 Balo Andrew K EVP, Clinical and Regulatory 2016-09-07 Sell4,9994.00%$94.45472,156130,01056.34%0013,444.50
DXCM DexCom Inc$147.66 Balo Andrew K EVP, Clinical and Regulatory 2016-08-24 Sell5,0004.00%$91.72458,600129,97960.99%0013,444.50
10 20 40 60 80 100 Total 106
  • 1
  • 2
  • 3